Full metadata record

DC Field Value Language
dc.contributor.authorKwag, Rina-
dc.contributor.authorLee, Jieon-
dc.contributor.authorKim, Doyoung-
dc.contributor.authorLee, Haeun-
dc.contributor.authorYeom, Miyoung-
dc.contributor.authorWoo, Jiwan-
dc.contributor.authorCho, Yakdol-
dc.contributor.authorKim, Hak Joong-
dc.contributor.authorKim, Jeongjin-
dc.contributor.authorKeum, Gyochang-
dc.contributor.authorJeon, Byungsun-
dc.contributor.authorChoo, Hyunah-
dc.date.accessioned2024-01-19T14:01:48Z-
dc.date.available2024-01-19T14:01:48Z-
dc.date.created2021-10-21-
dc.date.issued2021-09-
dc.identifier.issn0022-2623-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/116555-
dc.description.abstract5-HT7R belongs to a family of G protein-coupled receptors and is associated with a variety of physiological processes in the central nervous system via the activation of the neurotransmitter serotonin (5-HT). To develop selective and biased 5-HT7R ligands, we designed and synthesized a series of pyrazolyl-diazepanes 2 and pyrazolyl-piperazines 3, which were evaluated for binding affinities to 5-HTR subtypes and functional selectivity for G protein and beta-arrestin signaling pathways of 5-HT7R. Among them, 1-(3-(3-chlorophenyl)-1H-pyrazol-4-yl)-1,4-diazepane 2c showed the best binding affinity for 5-HT7R and selectivity over other 5-HTR subtypes. It was also revealed as a G protein-biased antagonist. The self-grooming behavior test was performed with 2c in vivo with Shank3(-/-) transgenic (TG) mice, wherein 2c significantly reduced self-grooming duration time to the level of wild-type mice. The results suggest that 5-HT7R could be a potential therapeutic target for treating autism spectrum disorder stereotypy.-
dc.languageEnglish-
dc.publisherAMER CHEMICAL SOC-
dc.titleDiscovery of G Protein-Biased Antagonists against 5-HT7R-
dc.typeArticle-
dc.identifier.doi10.1021/acs.jmedchem.1c01093-
dc.description.journalClass1-
dc.identifier.bibliographicCitationJOURNAL OF MEDICINAL CHEMISTRY, v.64, no.18, pp.13766 - 13779-
dc.citation.titleJOURNAL OF MEDICINAL CHEMISTRY-
dc.citation.volume64-
dc.citation.number18-
dc.citation.startPage13766-
dc.citation.endPage13779-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000701513400038-
dc.identifier.scopusid2-s2.0-85115981902-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusCOUPLED RECEPTORS-
dc.subject.keywordPlusSEROTONIN RECEPTORS-
dc.subject.keywordPlusLIGANDS-
dc.subject.keywordPlusDESIGN-
dc.subject.keywordPlusMODEL-
dc.subject.keywordPlusMOUSE-
dc.subject.keywordPlusDRUG-
dc.subject.keywordPlusSCHIZOPHRENIA-
dc.subject.keywordPlusPHARMACOPHORE-
dc.subject.keywordPlusOPTIMIZATION-
dc.subject.keywordAuthorautism spectrum disorder-
dc.subject.keywordAuthorGPCR-
dc.subject.keywordAuthor5-HT7R-
dc.subject.keywordAuthorneurodevelopmental disorders-
dc.subject.keywordAuthorbiased antagonist-
Appears in Collections:
KIST Article > 2021
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE